APA

Ruf R. G., Lichtenberger A., Karle S. M., Haas J. P., Anacleto F. E., Schultheiss M., Zalewski I., Imm A., Ruf E., Mucha B., Bagga A., Neuhaus T., Fuchshuber A., Bakkaloglu A. & Hildebrandt F. (20041004). Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. : Journal of the American Society of Nephrology : JASN.

Chicago

Ruf Rainer G, Lichtenberger Anne, Karle Stephanie M, Haas Johannes P, Anacleto Franzisco E, Schultheiss Michael, Zalewski Isabella, Imm Anita, Ruf Eva-Maria, Mucha Bettina, Bagga Arvind, Neuhaus Thomas, Fuchshuber Arno, Bakkaloglu Aysin and Hildebrandt Friedhelm. 20041004. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. : Journal of the American Society of Nephrology : JASN.

Harvard

Ruf R. G., Lichtenberger A., Karle S. M., Haas J. P., Anacleto F. E., Schultheiss M., Zalewski I., Imm A., Ruf E., Mucha B., Bagga A., Neuhaus T., Fuchshuber A., Bakkaloglu A. and Hildebrandt F. (20041004). Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. : Journal of the American Society of Nephrology : JASN.

MLA

Ruf Rainer G, Lichtenberger Anne, Karle Stephanie M, Haas Johannes P, Anacleto Franzisco E, Schultheiss Michael, Zalewski Isabella, Imm Anita, Ruf Eva-Maria, Mucha Bettina, Bagga Arvind, Neuhaus Thomas, Fuchshuber Arno, Bakkaloglu Aysin and Hildebrandt Friedhelm. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. : Journal of the American Society of Nephrology : JASN. 20041004.